Pharma

Akums Drugs and Pharmaceuticals Ltd

AKUMS · NSE · INE09XN01023
₹680.7+1.75%consolidatedstandalone
Monday, 26 Oct 2026Vol: 1.8L traded · 55.2% delivered2:16 pm
Sentiment64 · Greed
Extreme FearFearNeutralGreedExtreme Greed
Market Cap₹10,422 Cr
P/E35.7
P/B3.2
EPS₹19.05
Div Yield0.2%
ROE8.1%
ROCE8.8%
ROE8.1%
1Y Return+78.79%
Avg. Volume0.3M
Delivery %55.2%

Price Chart

82572261951741419.8L39.7LOct 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jul 2026Oct 2026

52-Week Range

₹409.3₹680.7₹838.8
52W Low52W High

About

Akums Drugs and Pharmaceuticals Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap₹10,422 Cr
Current Price₹680.7
52W High / Low₹838.8 / ₹409.3
Stock P/E35.7
Price to Book3.2
EPS (TTM)₹19.05
Dividend Yield0.2%
ROE8.1%
1Y Return+78.79%
Day Change+1.75%

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY16FY15
Sales₹4,502 Cr₹4,359 Cr₹4,118 Cr
Expenses₹3,934 Cr₹3,837 Cr₹3,654 Cr
Operating Profit₹568 Cr₹522 Cr₹465 Cr
OPM %13.0%12.0%11.0%
Other Income₹112 Cr₹108 Cr₹69 Cr
Depreciation₹159 Cr₹155 Cr₹153 Cr
Interest₹96 Cr₹94 Cr₹35 Cr
Profit Before Tax₹426 Cr₹382 Cr₹345 Cr
Tax₹133 Cr₹126 Cr₹1 Cr
Net Profit₹293 Cr₹256 Cr₹344 Cr
EPS (₹)18.516.221.5
Dividend Payout %—18%0%
Financial history locked

Register free to see 7 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹1,167 Cr₹1,158 Cr₹1,160 Cr₹1,018 Cr
Expenses₹992 Cr₹1,006 Cr₹1,013 Cr₹923 Cr
Operating Profit₹175 Cr₹152 Cr₹147 Cr₹94 Cr
OPM %15.0%13.0%13.0%9.0%
Depreciation₹41 Cr₹40 Cr₹40 Cr₹38 Cr
Interest₹25 Cr₹24 Cr₹24 Cr₹23 Cr
Net Profit₹101 Cr₹81 Cr₹68 Cr₹43 Cr
EPS (₹)6.45.44.22.6
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY16FY15
Liabilities
Equity Capital₹31 Cr₹31 Cr₹29 Cr
Reserves₹3,283 Cr₹3,016 Cr₹681 Cr
Borrowings₹157 Cr₹88 Cr₹565 Cr
Other Liabilities₹1,958 Cr₹960 Cr₹2,229 Cr
Total Liabilities₹5,429 Cr₹4,095 Cr₹3,504 Cr
Assets
Fixed Assets₹1,456 Cr₹1,397 Cr₹1,191 Cr
Investments₹0 Cr₹0 Cr₹0 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹3,796 Cr₹2,535 Cr₹2,118 Cr
Total Assets₹5,429 Cr₹4,095 Cr₹3,504 Cr
Balance sheet history locked

Register free to see 7 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹1,181 Cr₹-930 Cr₹34 Cr₹285 Cr
FY25₹465 Cr₹-548 Cr₹73 Cr₹-10 Cr
FY24₹498 Cr₹-331 Cr₹-108 Cr₹59 Cr
FY23
FY22
FY21
FY20
FY16
FY15
Cash flow history locked

Register free to see 7 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
3B BlackBio Dx Ltd₹1,210 Cr21.4+20.2%+17.9%
Aarey Drugs & Pharmaceuticals Ltd——+2.75%+59.84%
Aarti Drugs Ltd₹3,429 Cr18.0+13.37%+11.57%
Aarti Pharmalabs Ltd₹7,495 Cr35.2+8.51%+14.26%
Abbott India Ltd——+34.46%-7.16%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-16Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE Filing2026-08-13Akums Drugs and Pharmaceuticals Ltd (BOM:544222) (Q1 2027) Earnings Call Highlights: CDMO ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.